Gastric cytoprotection with non-antisecretory doses of prostaglandins
US4097603A · kind A · utility
9Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 6, 1977 |
| Grant date | Jun 27, 1978 |
| Priority date | — |
| Expiry date | Sep 6, 1997 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for prophylaxis of certain gastric inflammatory diseases by administration of gastric cytoprotective prostaglandins. Gastric cytoprotective prostaglandins refer to those prostaglandin-type compounds which are useful in reducing or preventing development of ulcers and other gastric lesions in the rat challenged by ingestion of ethanol, but which exhibit substantially no gastric antisecretory effects at the effective dosage for the present method.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.